Hyperplasia of axillary nodes in patients undergoing immunotherapy

E Loyer; C David; A Sella; J Ellerhorst

doi:10.2214/ajr.169.5.9353459

Hyperplasia of axillary nodes in patients undergoing immunotherapy

AJR Am J Roentgenol. 1997 Nov;169(5):1359-62. doi: 10.2214/ajr.169.5.9353459.

Authors

E Loyer¹, C David, A Sella, J Ellerhorst

Affiliation

¹ Diagnostic Radiology Department, University of Texas MD Anderson Cancer Center, Houston 77030, USA.

PMID: 9353459
DOI: 10.2214/ajr.169.5.9353459

Abstract

Objective: CT scans of the chest in 32 patients undergoing immunotherapy for metastatic renal cell carcinoma were evaluated to determine the incidence and significance of axillary lymph node enlargement during therapy.

Conclusion: Axillary node enlargement in cancer patients undergoing immunotherapy should not be assumed to be metastatic in origin but may result from the stimulation of the immune system during treatment.

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Axilla
Carcinoma, Renal Cell / secondary
Carcinoma, Renal Cell / therapy*
Fluorouracil / administration & dosage
Humans
Hyperplasia
Immunotherapy*
Interferon-alpha / administration & dosage
Interleukin-2 / administration & dosage
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy*
Lymph Nodes / diagnostic imaging
Lymph Nodes / pathology*
Lymphatic Metastasis
Retrospective Studies
Tomography, X-Ray Computed

Substances

Interferon-alpha
Interleukin-2
Fluorouracil